T. Burke

446 total citations
11 papers, 356 citations indexed

About

T. Burke is a scholar working on Molecular Biology, Oncology and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, T. Burke has authored 11 papers receiving a total of 356 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 4 papers in Oncology and 2 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in T. Burke's work include Cancer therapeutics and mechanisms (3 papers), Analytical Chemistry and Sensors (2 papers) and Advanced Breast Cancer Therapies (1 paper). T. Burke is often cited by papers focused on Cancer therapeutics and mechanisms (3 papers), Analytical Chemistry and Sensors (2 papers) and Advanced Breast Cancer Therapies (1 paper). T. Burke collaborates with scholars based in United States, Canada and Greece. T. Burke's co-authors include Jerald Fagliano, Marcia Goldoft, Douglas R. Geraets, R. Steven Esworthy, Fong‐Fong Chu, James H. Doroshow, Steven A. Akman, Julie G. Hensler, Peter J. Ferguson and Sang Ho Lee and has published in prestigious journals such as Oncogene, Brain Research and Environmental Health Perspectives.

In The Last Decade

T. Burke

11 papers receiving 343 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
T. Burke United States	11	111	96	87	73	44	11	356
C Lasne France	13	208 1.9×	119 1.2×	87 1.0×	22 0.3×	9 0.2×	30	571
Arthur Chiu United States	14	236 2.1×	216 2.3×	54 0.6×	32 0.4×	17 0.4×	29	586
Harshal Nemade Germany	10	210 1.9×	81 0.8×	46 0.5×	62 0.8×	26 0.6×	18	551
Abjal Pasha Shaik Saudi Arabia	16	174 1.6×	260 2.7×	41 0.5×	102 1.4×	26 0.6×	39	799
Pratima Khandayataray India	6	110 1.0×	60 0.6×	16 0.2×	29 0.4×	45 1.0×	17	334
Elizabeth A. Pease United States	13	214 1.9×	124 1.3×	30 0.3×	148 2.0×	6 0.1×	15	879
Sharon D. Shelton United States	14	193 1.7×	62 0.6×	57 0.7×	15 0.2×	17 0.4×	26	626
Zbigniew Plewa Poland	6	70 0.6×	27 0.3×	82 0.9×	20 0.3×	12 0.3×	13	321
T. Kiss Hungary	10	73 0.7×	55 0.6×	41 0.5×	34 0.5×	5 0.1×	16	426
J. Camakaris Australia	9	118 1.1×	197 2.1×	100 1.1×	27 0.4×	9 0.2×	11	521

Countries citing papers authored by T. Burke

Since Specialization

Citations

This map shows the geographic impact of T. Burke's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by T. Burke with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites T. Burke more than expected).

Fields of papers citing papers by T. Burke

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by T. Burke. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by T. Burke. The network helps show where T. Burke may publish in the future.

Co-authorship network of co-authors of T. Burke

This figure shows the co-authorship network connecting the top 25 collaborators of T. Burke. A scholar is included among the top collaborators of T. Burke based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with T. Burke. T. Burke is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

11 of 11 papers shown

Chen, S-H, Robert D. Van Horn, Taiqi Yin, et al.. (2017). RAF inhibitor LY3009120 sensitizes RAS or BRAF mutant cancer to CDK4/6 inhibition by abemaciclib via superior inhibition of phospho-RB and suppression of cyclin D1. Oncogene. 37(6). 821–832. 58 indexed citations

Devenish, John, Brian W. Brooks, Kay Perry, et al.. (2005). Validation of a Monoclonal Antibody-Based Capture Enzyme-Linked Immunosorbent Assay for Detection of Campylobacter fetus. Clinical and Vaccine Immunology. 12(11). 1261–1268. 17 indexed citations

Burke, T., et al.. (2004). The effect of DB-67, a lipophilic camptothecin derivative, on topoisomerase I levels in non-small-cell lung cancer cells. Cancer Chemotherapy and Pharmacology. 54(4). 354–60. 15 indexed citations

Sullivan, Nicole R., et al.. (2004). Effect of valproic acid on serotonin‐2A receptor signaling in C6 glioma cells. Journal of Neurochemistry. 90(5). 1269–1275. 15 indexed citations

Burke, T., et al.. (2002). Selective heterologous regulation of 5-HT1A receptor-stimulated [35S]GTPγS binding in the anterior cingulate cortex as a result of 5-HT2 receptor activation. Brain Research. 957(1). 174–182. 14 indexed citations

Burke, T., Sang Ho Lee, Peter J. Ferguson, & James R. Hammond. (1998). Interaction of 2′,2′-Difluorodeoxycytidine (Gemcitabine) and Formycin B with the Na+-Dependent and -Independent Nucleoside Transporters of Ehrlich Ascites Tumor Cells. Journal of Pharmacology and Experimental Therapeutics. 286(3). 1333–1340. 24 indexed citations

Bolger, Randall E., et al.. (1997). Fluorescent Dye Assay for Detection of DNA in Recombinant Protein Products. BioTechniques. 23(3). 532–537. 13 indexed citations

Doroshow, James H., Steven A. Akman, R. Steven Esworthy, Fong‐Fong Chu, & T. Burke. (1991). Doxorubicin Resistance Conferred by Selective Enhancement of Intracellular Glutathione Peroxidase or Superoxide Dismutase Content in Human MCF-7 Breast Cancer Cells. Free Radical Research Communications. 13(1). 779–781. 38 indexed citations

Burke, T., et al.. (1991). Chromite ore processing residue in Hudson County, New Jersey.. Environmental Health Perspectives. 92. 131–137. 123 indexed citations

10.

Geraets, Douglas R. & T. Burke. (1990). Sustained-release dosage forms.. PubMed. 80(2). 141–4. 17 indexed citations

11.

Burke, T., et al.. (1988). Selectivity of the anthracyclines for negatively charged model membranes: role of the amino group. Cancer Chemotherapy and Pharmacology. 21(4). 274–80. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact